There were no statistically significant differences between these 2 groups (P=0.668, 0.729, 0.614, and 0.955 at weeks 12, 24, 52, and 104, respectively).
lamivudine (LAM) (100 mg/day
adefovir (ADV) (10 mg/day)
HBeAg levels